輸入代號或公司名稱後按 Enter
LAB

STANDARD BIOTOOLS INC.

+0.03 (+3.54%)前一交易日收盤 2026-09-17
美股 · Nasdaq · 製藥生技 · 製藥SIC 2834
0.74USD157K成交股數289M市值3.3本益比(近四季)3.4股價營收比-7.6%營收年增(近四季)2026-11-03下次財報

財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束

逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。

營收與利潤率近 16 季

稀釋 EPS近 16 季 · 美元

現金流近 16 季

股東回饋近 16 季 · 庫藏股與股利

損益表 逐季 · 最新在左 · 小字是年增率

科目26Q226Q125Q325Q225Q124Q424Q324Q224Q123Q323Q223Q1
營收20.1M-1%21.1M+2276%19.6M-11%21.8M-3%20.2M-56%890K-96%22.1M-20%22.5M-10%45.5M25.4M27.7M25.1M
營業成本9.6M9.8M10.1M11.1M9.2M2.7M10.0M12.1M21.4M14.2M14.1M12.8M
毛利10.5M-5%11.3M-726%9.5M-22%10.6M+2%11.0M-54%−1.8M-116%12.1M-11%10.4M-16%24.2M11.2M13.6M12.3M
毛利率52.4%53.5%48.5%48.8%54.6%-202.8%54.9%46.1%53.1%44.0%49.2%48.9%
研發費用2.0M2.1M6.4M6.2M5.4M−1.3M6.9M7.2M16.0M6.4M6.2M6.4M
銷售管理費用16.4M18.6M26.6M28.1M29.8M6.8M24.5M24.9M46.9M22.3M22.6M21.3M
營業利益−25.4M-6%−12.5M+21%−32.9M+23%−25.7M-15%−27.0M-55%−10.3M-51%−26.7M+53%−30.3M+82%−60.2M−21.2M−17.4M−16.6M
營業利益率-126.3%-59.1%-168.5%-118.1%-133.4%-1,162.1%-120.9%-134.5%-132.2%-83.5%-63.1%-66.1%
稅後淨利−26.8M+3%127M-473%−34.7M+29%−33.5M-27%−26.0M-19%−34.1M+62%−26.9M+58%−45.7M+171%−32.2M−21.0M−17.0M−16.8M
淨利率-133.1%600.9%-177.4%-153.7%-128.7%-3,828.3%-122.0%-203.3%-70.6%-82.8%-61.6%-67.1%
稀釋 EPS-0.070%0.33-650%-0.09+29%-0.09-25%-0.07-74%-0.06-78%-0.07-68%-0.12-43%-0.27-0.27-0.22-0.21
稀釋股數391M388M383M380M378M353M372M372M294M79.2M78.7M79.1M

資產負債表 期末餘額

科目26Q226Q125Q325Q225Q124Q424Q324Q224Q123Q323Q223Q1
現金與約當現金270M266M129M159M151M167M211M270M287M79.7M142M114M
應收帳款15.7M16.6M13.5M14.6M35.5M14.7M35.3M32.4M36.0M16.6M15.1M14.5M
存貨17.1M18.6M25.4M24.2M42.1M20.7M42.6M42.6M40.4M21.9M22.1M22.5M
總資產627M639M540M557M580M612M682M709M778M339M356M372M
有息負債299K55.2M55.1M55.0M64.6M65.2M
總負債87.2M78.0M140M132M125M141M192M198M200M160M158M158M
股東權益540M561M400M425M455M472M489M510M577M−132M−113M−97.2M
負債比13.9%12.2%25.9%23.8%21.6%23.0%28.2%28.0%25.8%47.1%44.4%42.4%
淨現金(現金 − 有息負債)166M155M215M232M15.1M77.1M

現金流量表 單季

科目26Q226Q125Q325Q225Q124Q424Q324Q224Q123Q323Q223Q1
營業現金流−46.6M−30.3M-52%−62.5M−8.5M
資本支出570K5.1M781K1.0M
自由現金流−47.2M−35.3M-44%−63.3M−9.5M
折舊攤銷1.4M3.3M−393K3.9M3.9M5.2M4.0M3.6M3.7M
買回庫藏股0.0011.1M400K2.4M2.5M
現金股利
自由現金流率-223.1%-174.7%-138.9%-37.8%

營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度

地區2025 年度 · 85.3M
歐洲中東非洲36.0M42.2%+0.9%
美洲30.6M35.8%-18.3%
亞太18.8M22.0%+4.6%
產品/服務2025 年度 · 109M
Consumables36.2M33.3%-10.6%
Instruments25.4M23.3%+2.1%
Service And Other Revenue23.7M21.7%-7.5%
Services And Other Revenue23.7M21.7%-7.5%
產品 小計61.7M56.6%-5.8%

各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。

年度 10-K

財年營收年增稅後淨利淨利率稀釋 EPS自由現金流
FY202585.3M-6.2%−74.9M-87.8%-0.20−82.6M
FY202491.0M-14.4%−139M-152.6%-0.52−152M
FY2023106M+8.6%−74.7M-70.2%-0.94−46.1M
FY202297.9M-25.0%−190M-194.1%-2.43−93.2M
FY2021131M-5.5%−59.2M-45.4%-0.78−57.3M
FY2020138M+17.8%−53.0M-38.4%-0.74−28.1M
FY2019117M+3.8%−64.8M-55.3%-0.97−37.7M
FY2018113M−59.0M-52.2%-1.49−25.6M